Thu, January 3, 2019
Wed, January 2, 2019
Mon, December 31, 2018
Fri, December 28, 2018
Thu, December 27, 2018
Wed, December 26, 2018
Fri, December 21, 2018
Thu, December 20, 2018

Amit Hazan Downgraded (ABT) to Strong Sell and Decreased Target to $68 on, Jan 2nd, 2019

Amit Hazan of Citigroup, Downgraded "Abbott Laboratories" (ABT) to Strong Sell and Decreased Target from $72 to $68 on, Jan 2nd, 2019.

Amit has made no other calls on ABT in the last 4 months.



There are 6 other peers that have a rating on ABT. Out of the 6 peers that are also analyzing ABT, 0 agree with Amit's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Amit


  • Matt Miksic of "Credit Suisse" Initiated at Buy and Held Target at $82 on, Tuesday, December 18th, 2018
  • Isaac Ro of "Goldman Sachs" Upgraded from Hold to Strong Buy and Increased Target to $81 on, Friday, November 30th, 2018
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $79 on, Thursday, October 18th, 2018
  • Matthew Taylor of "Barclays" Initiated at Buy and Held Target at $80 on, Tuesday, October 16th, 2018
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $81 on, Monday, October 8th, 2018
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $80 on, Monday, September 24th, 2018